Deprescribing in cognitively vulnerable older people: development and validation of STOPPCog criteria
Age and Ageing · 2025
DOI: 10.1093/ageing/afaf014 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Age and Ageing, 2025. Verfasst von Siobhan McGettigan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (Geriatrics), University College Cork College of Medicine, Cork, T12K8AF, Ireland. Hauptthemen laut MEDLINE: Deprescriptions, Cognition, Potentially Inappropriate Medication List, Inappropriate Prescribing. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Objective
To validate STOPPCog, a list of explicit criteria for potentially inappropriate medication use in cognitively vulnerable older adults.
Design
A Delphi consensus survey of an expert panel comprising academic geriatricians, old age psychiatrists, general practitioners, and clinical pharmacists.
Setting
Ireland. Subjects Nine panellists.
Methods
STOPPCog criteria were initially created by the authors based on clinical experience and literature appraisal. Criteria were organised according to drug/drug class. Using Delphi consensus methodology, panellists ranked their agreement with each criterion on a 5-point Likert scale and provided written feedback. Criteria with a median value of 1 or 2 (strongly agree/agree) and a 25th centile value of ≤2 were included in the final list.
Results
All panellists completed two Delphi consensus validation rounds. Twenty-five criteria were proposed initially, twenty were accepted. One criterion was rejected (multi-vitamin supplements), and four criteria were rephrased (two of these were combined to one criterion for greater clarity). The final list comprised 23 criteria that are arranged in six subgroups i.e. (i) drugs with anticholinergic properties taken daily; (ii) drugs with sedative properties taken daily; (iii) drugs that may exacerbate psychotic symptoms in patients with alpha-synuclein pathology; (iv) drugs used for chronic pain; (v) drugs without proven efficacy for dementia taken daily; (vi) drugs that are of no proven benefit in advanced stage dementia i.e. clinical dementia rating of 3.0 where palliation may be appropriate.
Conclusion
STOPPCog comprises 23 criteria relating to medications that are potentially inappropriate in cognitively vulnerable older adults. STOPPCog may assist physicians in deprescribing medications in this patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine (Geriatrics), University College Cork College of Medicine, Cork, T12K8AF, Ireland.
- Department of Geriatric Medicine, Cork University Hospital, Wilton, Cork, T12DC4A, Ireland.
ORCID-Profile: Siobhan McGettigan, Denis Curtin, Denis O'Mahony
Zitieren
APA
McGettigan, S., Curtin, D., & O'Mahony, D. (2025). Deprescribing in cognitively vulnerable older people: development and validation of STOPPCog criteria. Age and Ageing. https://doi.org/10.1093/ageing/afaf014
Vancouver
McGettigan S, Curtin D, O'Mahony D. Deprescribing in cognitively vulnerable older people: development and validation of STOPPCog criteria. Age and Ageing. 2025. doi:10.1093/ageing/afaf014
BibTeX
@article{McGettigan2025,
author = {McGettigan, Siobhan and Curtin, Denis and O'Mahony, Denis},
title = {Deprescribing in cognitively vulnerable older people: development and validation of STOPPCog criteria},
journal = {Age and Ageing},
year = {2025},
doi = {10.1093/ageing/afaf014}
}
EUVIMED